Q1 2023 Holdings
Filed 2023-05-15 | 49 holdings | $1.4B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Hillevax Inc | COM | 43157M102 | $161.7M | 9,781,472 | 11.7% |
| Newamsterdam Pharma Company(NAMS) | ORDINARY SHARES | N62509109 | $125.6M | 9,341,551 | 9.1% |
| Chinook Therapeutics Inc(290A) | COM | 16961L106 | $100.6M | 4,345,559 | 7.3% |
| Arcutis Biotherapeutics(ARQT) | COM | 03969K108 | $95.5M | 8,684,232 | 6.9% |
| Mirum Pharmaceuticals, Inc.(MIRM) | COM | 604749101 | $92.7M | 3,860,107 | 6.7% |
| Syndax Pharmaceuticals, Inc.(SNDX) | COM | 87164F105 | $78.3M | 3,708,838 | 5.7% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $75.7M | 945,407 | 5.5% |
| Phathom Pharmaceuticals, Inc.(PHAT) | COM | 71722W107 | $60.0M | 8,407,152 | 4.3% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $59.1M | 2,944,349 | 4.3% |
| Vaxcyte, Inc.(PCVX) | COM | 92243G108 | $52.4M | 1,397,405 | 3.8% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $38.6M | 2,164,739 | 2.8% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $25.5M | 3,238,859 | 1.8% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $23.3M | 2,159,154 | 1.7% |
| Alpine Immune Sciences Inc(NVLSEUR) | COM | 02083G100 | $23.1M | 2,985,757 | 1.7% |
| Tyra Biosciences Inc(TYRA) | COM | 90240B106 | $22.8M | 1,421,310 | 1.7% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $22.7M | 1,414,823 | 1.6% |
| Tarsus Pharmaceuticals, Inc.(TARS) | COM | 87650L103 | $22.5M | 1,787,527 | 1.6% |
| Theseus Pharmaceuticals Inc | COM | 88369M101 | $20.0M | 2,248,194 | 1.4% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $19.6M | 899,700 | 1.4% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $19.4M | 1,171,650 | 1.4% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $18.5M | 854,484 | 1.3% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $18.2M | 830,983 | 1.3% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $16.1M | 857,338 | 1.2% |
| Gritstone BIO Inc(2JQ) | COM | 39868T105 | $14.4M | 5,162,348 | 1.0% |
| Merus N V | COM | N5749R100 | $13.7M | 746,479 | 1.0% |
| Trevi Therapeutics Inc(TRVI) | COM | 89532M101 | $12.3M | 6,663,590 | 0.9% |
| Macrogenics Inc(MGNX) | COM | 556099109 | $12.2M | 1,703,204 | 0.9% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $12.1M | 686,762 | 0.9% |
| Vectivbio Hldg AG | ORD SHS | H9060V101 | $11.6M | 1,352,199 | 0.8% |
| Cerevel Therapeutics Hldng I(CERE1EUR) | COM | 15678U128 | $9.6M | 393,000 | 0.7% |
| Immunovant, Inc.(IMVT) | COM | 45258J102 | $9.1M | 585,759 | 0.7% |
| Sutro Biopharma Inc | COM | 869367102 | $8.2M | 1,776,479 | 0.6% |
| Morphic Hldg Inc | COM | 61775R105 | $8.1M | 214,240 | 0.6% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $7.8M | 285,331 | 0.6% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $7.7M | 500,000 | 0.6% |
| Intellia Therapeutics Inc(NTLA) | COM | 45826J105 | $7.6M | 203,684 | 0.5% |
| Autolus Therapeutics PLC(AUTL) | SPON ADS | 05280R100 | $6.9M | 3,746,857 | 0.5% |
| Aerovate Therapeutics Inc | COM | 008064107 | $6.8M | 338,110 | 0.5% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $6.2M | 127,900 | 0.4% |
| Zymeworks Inc(ZYME) | COM | 98985Y108 | $5.5M | 610,000 | 0.4% |
| Silence Therapeutics PLC(SLN) | ADS | 82686Q101 | $5.5M | 881,173 | 0.4% |
| Allakos Inc(ALLKGUSD) | COM | 01671P100 | $5.0M | 1,112,684 | 0.4% |
| Bluebird BIO Inc | COM | 09609G100 | $4.6M | 1,440,757 | 0.3% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $4.6M | 682,461 | 0.3% |
| Passage Bio, Inc. | COM | 702712100 | $3.6M | 3,756,915 | 0.3% |
| ADC Therapeutics SA(ADCT) | SHS | H0036K147 | $3.2M | 1,647,030 | 0.2% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $2.1M | 264,377 | 0.2% |
| Newamsterdam Pharma Company | *W EXP 11/22/202 | N62509117 | $920.6K | 500,333 | 0.1% |
| Nabriva Therapeutics PLC | SHS NEW 2022 | G63637139 | $29.7K | 17,025 | 0.0% |